monotropein has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y; Hu, S; Qin, L; Shen, Y; Song, Z; Zhang, Q; Zhao, Z | 1 |
| Han, T; He, YQ; Hsu, HY; Lin, B; Liu, LL; Qin, LP; Shen, Y; Song, HT; Xin, HL; Yang, H; Zhang, JH; Zhang, QY; Zhang, ZG | 1 |
2 other study(ies) available for monotropein and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Monotropein Protects against Inflammatory Bone Loss and Suppresses Osteoclast Formation and Bone Resorption by Inhibiting NFATc1 via NF-κB and Akt/GSK-3β Pathway.
Topics: Actins; Animals; Bone Resorption; Cathepsin K; Glycogen Synthase Kinase 3 beta; Interleukin-1beta; Interleukin-6; Iridoid Glycosides; Iridoids; Ligands; Lipopolysaccharides; Matrix Metalloproteinase 9; Mice; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Proto-Oncogene Proteins c-akt; Tartrate-Resistant Acid Phosphatase; TNF Receptor-Associated Factor 6 | 2022 |
Monotropein attenuates ovariectomy and LPS-induced bone loss in mice and decreases inflammatory impairment on osteoblast through blocking activation of NF-κB pathway.
Topics: Alkaline Phosphatase; Animals; Bone Density; Bone Matrix; Bone Resorption; Calcification, Physiologic; Cell Cycle; Cell Line; Cell Proliferation; Female; Femur; Inflammation; Interleukin-1beta; Interleukin-6; Iridoids; Lipopolysaccharides; Mice, Inbred C57BL; NF-kappa B; Osteoblasts; Osteocalcin; Osteoporosis; Ovariectomy; Signal Transduction; X-Ray Microtomography | 2018 |